Cure means complete disappearance of disease and restoration of health.
For prostate cancer,many of the data points used to assess the stage of a man’s prostate cancer and his risk for progression of the disease are affected by physician subjectivity for interpreting scale of disorder. If the data points can be so affected by subjectivity then they lack accuracy and therefore the cure rates generated by these data points lack reliability. Because of these concerns for lack of reliability and lack of reproducibility in generating cure rates for prostate cancer,the use of the term survival seems more appropriate as it is less limiting when applied to prostate cancer treatment success.
T1c stage prostate cancer is the most common presentation for prostate cancer currently and is detected because of an abnormal PSA.
This T1c stage defines a localized prostate cancer and the survival benefits between the four different treatment categories for localized prostate cancer are similar. However,of these treatment options for localized prostate cancer,only HIFU is the most precise as well as affording a superior post treatment quality of life (QOL). The continued evolution of this state of the art technology should result in even greater prostate cancer survival benefits in the future.